KLIFO (Group)

https://www.klifo.com

KLIFO is a leading Northern European drug development consultancy with significant experience in partnering with biotech and pharmaceutical companies to advance their drug development projects. KLIFO provides end-to-end expert capabilities, enabling partners to maximise opportunity, mitigate risks, drive innovation and achieve efficient project advancement. The company offers multidisciplinary consulting and operational solutions spanning all clinical research areas, clinical trial supply, QA, CMC development, regulatory affairs, pharmacovigilance, and the development of pharmaceutical and biotech products and medical devices. *

	Start	1994-01-01 established
	Industry	drug development services
	Industry 2	clinical research services
	Person	Mørk, Alejandra (KLIFO 2008– Owner + CEO)

	Region	Glostrup
	Country	Denmark
	Street	36 Smedeland
	City	2600 Glostrup
	Tel	+45-44-222900
		Address record changed: 2021-06-12

Basic data	Employees	D: 101 to 500 (2021-05-06)

		* Document for »About Section«: Gilde Healthcare Partners. (5/6/21). "Press Release: Gilde Healthcare Acquires Majority Stake in Danish Drug Development Consultancy KLIFO to Support International Growth Ambitions". Utrecht & Copenhagen.

		Record changed: 2024-02-12

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for KLIFO (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)